Enantioselective HPLC-DAD method for the determination of etodolac enantiomers in tablets, human plasma and application to comparative pharmacokinetic study of both enantiomers after a single oral dose to twelve healthy volunteers

Talanta

Volumn 130, Issue , 2014, Pages 506-517

  Hewala, Ismail I ^a   Moneeb, Marwa S ^a   Elmongy, Hatem A ^b   Wahbi, Abdel Aziz M ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

^b Damanhour University   (Egypt)

Author keywords

Enantioselective HPLC DAD; Etodolac enantiomers; Pharmacokinetics; Solid phase extraction

Indexed keywords

CHROMATOGRAPHIC ANALYSIS; ENANTIOMERS; ENANTIOSELECTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PHARMACOKINETICS; PHASE SEPARATION; PLASMA (HUMAN);

CHROMATOGRAPHIC SYSTEMS; ENANTIOSELECTIVE HPLC; ETODOLAC; HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC METHODS; LIMIT OF QUANTIFICATIONS; PHOTODIODE ARRAY DETECTORS; SOLID PHASE EXTRACTION TECHNIQUES; SOLID-PHASE EXTRACTION;

EXTRACTION;

ETODOLAC; TABLET;

CHEMICAL MODEL; CHEMICAL STRUCTURE; CHEMISTRY; COMPARATIVE STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PLASMA; PROCEDURES; SOLID PHASE EXTRACTION; STEREOISOMERISM; TABLET; TISSUE DISTRIBUTION; YOUNG ADULT;

ADMINISTRATION, ORAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ETODOLAC; HEALTHY VOLUNTEERS; HUMANS; MALE; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PLASMA; SOLID PHASE EXTRACTION; STEREOISOMERISM; TABLETS; TISSUE DISTRIBUTION; YOUNG ADULT;

EID: 84905652394     PISSN: 00399140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.talanta.2014.07.011     Document Type: Article

References (39)

1. D.R. Brocks, and F. Jamali J. Pharm. Sci. 80 1991 1058 1061
2. S.C. Tan, B.K. Patel, S.H.D. Jackson, C.G. Swift, and A.J. Hutt Xenobiotica 32 2002 683 697
3. C.R. Craig, and R.E. Stitzel Modern Pharmacology with Clinical Applications sixth edition 2004 Lippincott Williams and Wilkins Philadelphia, USA
4. K. Glaser, M. Sung, K. O'Neill, M. Belfast, D. Hartman, R. Carlson, A. Kreft, D. Kubrak, C. Hsiao, and B. Weichman Euro. J. Pharmacol. 281 1995 107 111
5. H.S. Lee, I.M. Kang, H.W. Lee, J.H. Seo, J.H. Ryu, S.J. Choi, M.J. Lee, S.Y. Jeong, Y.W. Cho, and K.T. Lee J. Chromatogr. B 863 2008 158 162
6. J.P. Boni, J. Korth-Bradley, K. McGoldrick, A. Appel, and S. Cooper Clin. Pharmacol. 39 1999 729 737
7. F. Jamali, R. Lovlin, and G. Aberg Chirality 9 1997 29 31
8. J.W. Young, N.M. Gray, W.J. Wechter, Antipyretic and Analgesic Methods and Compositions Containing Optically Pure R-etodolac, United States Patent, Patent Number 5561151, Sepracor INC, USA, 1996.
9. P. Lees, P.M. Taylor, F.M. Landoni, A.K. Arifah, and C. Waters Vet. J. 165 2003 21 35
10. R.D. Raquel, G.R. Carmen, L.C. Antonio, and M.M. Luisa Electrophoresis 26 2005 1106 1113
11. D.A. Dilek, B.K. Özlem, T. Muzaffer, and Y.A. Hassan J. Liq. Chromatogr. Relat. Technol. 24 2010 773 780
12. S. Fanali, P. Catarcini, and C. Presutti J. Chromatogr. A 994 2003 227 232
13. N.N. Singh, F. Jamali, F.M. Pasutto, R.T. Coutts, and A.S. Russell J. Chromatogr. 382 1986 331 337
14. N.R. Srinivas, W.C. Shyu, and R.H. Barbhaiya Biomed. Chromatogr. 9 1995 1 9
15. C. Giachetti, A. Assandri, G. Zanolo, and E. Brembilla Biomed. Chromatogr. 8 1994 180 183
16. S. Caccamese Chirality 5 1993 164 167
17. I. Ali, and H.Y. Aboul-Enein Biomed. Chromatogr. 17 2003 113 117
18. A. Ghanem, M.N. Aboul-Enein, A. El-Azzouny, and M.F. El-Behairy J. Chromatogr. A 1217 2010 1063 1074
19. Y.X. Jin, Y.H. Tang, and S. Zeng J. Pharm. Biomed. Anal. 46 2008 953 958
20. C.C. Guo, Y.H. Tang, H.H. Hu, L.S. Yu, H.D. Jiang, and S. Zeng Pharm. Anal. 1 2011 184 190
21. F. Jamali, R. Mehvar, C. Lemko, and O. Eradiri J. Pharm. Sci. 77 1988 963 966
22. T. Higashi, M. Kawasaki, H. Tadokoro, S. Ogawa, H. Tsutsui, T. Fukushima, and T. Toyo'oka J. Sep. Sci. 35 2012 2840 2846
23. S. Ogawa, H. Tadokoro, M. Sato, T. Hanawa, and T. Higashi J. Chromatogr. B 940 2013 7 14
24. Y. Kazakevich, and R. Lobrutto HPLC for pharmaceutical scientists 2007 John Wiley and Sons Hopkens, New Jersy, USA
25. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Guidance for Industry, Bioanalytical Method Validation, May 2001, Internet at http://www.fda.gov/cder/ guidance/index.html.
26. J.C. Miller, and J.N. Miller Statistics and Chemometrics for Analytical Chemistry fifth edition 2005 Pearson Education Limited Harlow, England
27. L. Cuardos-Rodriguez, L. Gámiz-Gracia, E.M. Almansa-López, and J.M. Bosque-Sendra Trends Anal. Chem. 20 2003 620 636
28. A.M. Almeida, M.M. Castel-Branco, and A.C. Falcao Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods J. Chromatogr. B 774 2002 215 222 (Pubitemid 34655493)
29. S. Jing-min, L. Shun-guo, X. Chang-jiang, D. Geng-li, and L. Duan Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats Acta Pharmacol. Sin. 25 2004 996 999
30. R.E. Galinsky, and C.K. Svensson D.B. Troy, Remington the Science and Practice of Pharmacy Twenty First Ed. 2005 Lippincott Williams and Wilkins Philadelphia, PA, USA
31. Burger's medicinal chemistry and drug discovery Sixth Ed. D.J. Abraham Autocoids, diAgnostics, and Drugs from New Biology 4 2003 John Wiley and Sons Hopkens, New Jersy, USA
32. V.L. Campo, L.S. Bernardes, and I. Carvalho Curr. Drug Metab. 10 2009 188 205
33. H. Lu Drug Metab. Toxicol 3 2007 149 158
34. C. Zhu, L. Wang, F. Hua, X. Yu, and J. Zhang Eur. J. Pharm. Sci. 49 2013 761 766
35. R. Lavado, J. Li, J.M. Rimoldi, and D. Schlenk Toxicol. Lett. 226 2014 192 197
36. J. Caldwell, A.J. Hutt, and S. Fournel-Gigleux Biochem. Pharmacol. 37 1988 105 114
37. E. Neirinckx, S. Croubels, J.P. Remon, M. Devreese, P. De Backer, and C. Vervaet Vet. J. 190 2011 290 292
38. A.L. Soract, O. Tapia, and J. Garcia J. Vet. Pharmacol. Ther. 28 2005 65 70
39. R.D. Knihinicki, K.M. Williams, and R.O. Day Biochem. Pharmacol. 38 1989 4389 4395